当前位置:
X-MOL 学术
›
Lancet Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Oncolytic virus therapy in advanced melanoma
The Lancet Oncology ( IF 41.6 ) Pub Date : 2017-10-12 , DOI: 10.1016/s1470-2045(17)30782-9 Elizabeth Gourd
The Lancet Oncology ( IF 41.6 ) Pub Date : 2017-10-12 , DOI: 10.1016/s1470-2045(17)30782-9 Elizabeth Gourd
The combination of talimogene laherparepvec, an oncolytic virus, plus ipilimumab could be significantly more effective than ipilimumab alone for treating advanced, unresectable melanoma, according to the results of a recent study.
中文翻译:
溶瘤病毒治疗晚期黑素瘤
根据最近的一项研究结果,talimogene laherparepvec(一种溶瘤病毒)与ipilimumab的组合比单独使用ipilimumab的组合治疗晚期不可切除的黑色素瘤要有效得多。
更新日期:2017-11-10
中文翻译:
溶瘤病毒治疗晚期黑素瘤
根据最近的一项研究结果,talimogene laherparepvec(一种溶瘤病毒)与ipilimumab的组合比单独使用ipilimumab的组合治疗晚期不可切除的黑色素瘤要有效得多。